Advanced search
Publication Cover
Clinical Interventions in Aging Volume 18, 2023 - Issue
Submit an article Journal homepage
119
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Safety and Effectiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Aged Greater versus Less Than 80 Years

Lijie Zhang1 Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China;2 Key Laboratory of Molecular Imaging of Hubei Province, Wuhan, Hubei, ChinaORCID Iconhttps://orcid.org/0000-0002-6296-2219
ORCID Icon,
Wei Hong1 Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China;2 Key Laboratory of Molecular Imaging of Hubei Province, Wuhan, Hubei, China
,
Zizhuo Wang1 Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China;2 Key Laboratory of Molecular Imaging of Hubei Province, Wuhan, Hubei, China
,
Chuansheng Zheng1 Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China;2 Key Laboratory of Molecular Imaging of Hubei Province, Wuhan, Hubei, China
,
Bin Liang1 Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China;2 Key Laboratory of Molecular Imaging of Hubei Province, Wuhan, Hubei, ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-6130-8629
ORCID Icon &
Heshui Shi1 Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China;2 Key Laboratory of Molecular Imaging of Hubei Province, Wuhan, Hubei, China
Pages 1883-1892 | Received 27 Jul 2023, Accepted 05 Nov 2023, Published online: 13 Nov 2023

References

  • Sung H, Ferlay J, Siegel RL., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. doi:10.1016/j.jhep.2018.03.019
  • The European Commission and the Economic Policy Committee (AWG). The 2012 Ageing Report: Economic and Budgetary Projections for the EU27 Member States (2010–2060). Brussels: European Union; 2012.
  • Administration on Ageing, Administration for Community Living. A profile of Older Americans 2013: Washington US Department of Health and Human Services; 2014.
  • The Central People’s Government of the People’s Republic of China. Statistical Bulletin of China’s Health Development in 2021. Available from: http://www.gov.cn/xinwen/2022-07/12/content_5700670.htm. Accessed April 30, 2023.
  • Mosconi C, Gramenzi A, Biselli M, et al. Survival and tolerability of transarterial chemoembolization in greater versus less than 70 years of age patients with unresectable hepatocellular carcinoma: a propensity score analysis. Cardiovasc Intervent Radiol. 2020;43(7):1015–1024. doi:10.1007/s00270-020-02451-3
  • Mirici-Cappa F, Gramenzi A, Santi V, et al. Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience. Gut. 2010;59(3):387–396. doi:10.1136/gut.2009.194217
  • Nishikawa H, Kita R, Kimura T, et al. Transcatheter arterial chemoembolization for intermediate-stage hepatocellular carcinoma: clinical outcome and safety in elderly patients. J Cancer. 2014;5(7):590–597. doi:10.7150/jca.9413
  • Yau T, Yao TJ, Chan P, et al. The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization. Cancer. 2009;115(23):5507–5515. doi:10.1002/cncr.24636
  • The World Health Organization (WHO). New age classification standard-65 years old is still young. Available from: https://en.brilio,net/news/65-years-old-is-still-young-1601205.html#. Accessed April 30, 2023.
  • Liang B, Xiang H, Ma C, et al. Comparison of chemoembolization with CalliSpheres® microspheres and conventional chemoembolization in the treatment of hepatocellular carcinoma: a multicenter retrospective study. Cancer Manag Res. 2020;12:941–956. doi:10.2147/CMAR.S187203
  • Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(1):52–60. doi:10.1055/s-0030-1247132
  • Common Terminology Criteria for Adverse Events v.4.0 (CTCAE). NIH publication #09-7473. National Cancer institute; 2009. Available from: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm. Accessed April 30, 2023.
  • Cammarota A, D’Alessio A, Pressiani T, Rimassa L, Personeni N. Systemic treatment for older patients with unresectable Hepatocellular carcinoma. Drugs Aging. 2021;38(7):579–591. doi:10.1007/s40266-021-00871-5
  • Wang Z, Ren Z, Chen Y, et al. Adjuvant transarterial chemoembolization for HBV-related Hepatocellular Carcinoma After Resection: a randomized controlled study. Clin Cancer Res. 2018;24(9):2074–2081. doi:10.1158/1078-0432.CCR-17-2899
  • Yang J, Siri JG, Remais JV, et al. The Tsinghua-Lancet Commission on Healthy Cities in China: unlocking the power of cities for a healthy China. Lancet. 2018;391(10135):2140–2184. doi:10.1016/S0140-6736(18)30486-0
  • Cheng HM, Tanaka T, Nishiofuku H, et al. Safety and prognosis of transarterial chemoembolization for octogenarians with hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2019;42(10):1413–1419. doi:10.1007/s00270-019-02290-x

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.